Genetic analysis and functional characterization of prothrombins Corpus Christi (Arg382-Cys), Dhahran (Arg271-His), and hypoprothrombinemia

Blood

Volumn 88, Issue 7, 1996, Pages 2611-2618

  O'Marcaigh, Aengus S ^b   Nichols, William L ^a   Hassinger, Nancy L ^b   Mullins, James D ^b   Mallouh, Ahmad A ^b   Gilchrist, Gerald S ^b   Owen, Whyte G ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTHROMBIN;

ADULT; ARTICLE; BLOOD CLOTTING; CASE REPORT; FIBRIN FORMATION; GENETIC ANALYSIS; HEMOSTASIS; HUMAN; HYPOPROTHROMBINEMIA; MALE; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN STRUCTURE;

EID: 0029815902     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.7.2611.bloodjournal8872611     Document Type: Article

References (30)

1. Mann KG: Prothrombin and thrombin, in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA, Lippincott, 1994, p 184
2. Roberts HR, Lefkowitz JB: Inherited Disorders of Prothrombin Conversion, in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA, Lippincott, 1994, p 200
3. Tuddenham EGD, Cooper DN: The Molecular Genetics of Haemostasis and Its Inherited Disorders. Oxford, UK, Oxford University Press, 1994, p 145
4. Poort SR, Michiels JJ, Reitsma PH, Bertina RM: Homozygosity for a novel missense mutation in the prothrombin gene causing a severe bleeding disorder. Thromb Haemost 72:819, 1994
5. Iwahana H, Yoshimoto K, Shigekiyo T, Shirakami A, Saito S, Itakura M: Molecular and genetic analysis of a compound heterozygote for dysprothrombinemia of prothrombin Tokushima and hypoprothrombinemia. Am J Hum Genet 51:1386, 1992
6. Tamary H, Surrey S, Augustine JG, Schwartz E, Rappaport EF. Molecular characterization of hypoprothrombinemia. Blood 78:65a, 1991 (abstr, suppl 1)
7. Henriksen RA. Identification and characterization of mutant thrombins. Methods Enzymol 222:312, 1993
8. Degen SJF: Prothrombin, in High KA, Roberts HR (eds): Molecular Basis of Thrombosis and Hemostasis. New York, NY, Marcel Dekker, 1995, p 75
9. Morishita E, Saito M, Kumabashiri I, Asakura H, Matsuda T, Yamaguchi K: Prothrombin Himi: A compound heterozygote for two dysfunctional molecules (Met-337 to Thr and Arg-388 to His). Blood 80:2275, 1992
10. James HL, Kim DJ, Zheng DQ, Girolami A: Prothrombin Padua I: Incomplete activation due to an amino acid substitution at a factor Xa cleavage site. Blood Coagul Fibrinolysis 5:841, 1994
11. Degen SJF, McDowell SA, Sparkes LM, Scharrer I: Prothrombin Frankfurt: A dysfunctional prothrombin variant characterized by substitution of Glu 466 by Ala. Thromb Haemost 73:203, 1995
12. Laurell CB: Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Ann Biochem 15:45, 1966
13. Owen WG: Evidence for the formation of an ester between thrombin and heparin cofactor. Biochim Biophys Acta 405:380, 1975
14. Mustard JF, Perry DW, Ardlie NG, Packham MA: Preparation of suspensions of washed platelets from humans. Br J Haematol 22:193, 1972
15. Gustafson S, Proper JA, Bowie EJW, Sommer SS: Parameters affecting the yield of DNA from human blood. Anal Bioch 165:294, 1987
16. Stoflet ES, Koeberl DD, Sarkar G, Sommer SS: Genomic amplification with transcript sequencing. Science 239:491, 1988
17. Sarkar G, Yoon HS, Sommer SS: Dideoxy fingerprinting (ddF): A rapid and efficient screen for the presence of mutations. Genomics 13:441, 1992
18. Sommer SS, Sarkar G, Koeberl DD, Bottema CDK, Buerstedde JM, Schowalter DB, Cassady JD: Direct sequencing with the aid of phage promoters, in Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds): PCR Protocols: A Guide to Methods and Applications. New York, NY, Academic, 1990, p 197
19. Degen SJF, Davie EW: Nucleotide sequence of the gene for human prothrombin. Biochemistry 26:6165, 1987
20. Henriksen RA, Mann KG: Identification of the primary structural defect in the dysthrombin Thrombin Quick I: Substitution of cysteine for arginine-382. Biochemistry 27:9160, 1988
21. Henriksen RA, Owen WG: Characterization of the catalytic defect in the dysthrombin, Thrombin Quick. J Biol Chem 262:4664, 1987
22. Smith LG, Coone LA, Kitchens CS. Prothrombin Gainesville, a dysprothrombinemia in a pair of identical twins. Am J Hematol 11:223, 1981
23. Cote HC, Stevens WK, Bajzar L, Banfield DK, Nesheim ME, MacGillivray RT: Characterization of a stable form of human meizothrombin derived from recombinant prothrombin (R155A, R271A, and R284A). J Biol Chem 269:11374, 1994
24. Rabiet MJ, Furie BC, Furie B: Molecular defect of Prothrombin Barcelona, substitution of cysteine for arginine at residue 273. J Biol Chem 261:15045, 1986
25. Guillin MC, Bezeaud A: Characterization of a variant of human prothrombin: Prothrombin Madrid. Ann N Y Acad Sci 370:414, 1981
26. Polisson C, Morgan RD: Aci I, a unique restriction endonuclease from Arthrobacter citreus which recognizes 5′ CCGC 3′. Nucleic Acids Res 18:5911, 1990
27. Bottema CD, Ketterling RP, Vielhaber E, Yoon HS, Gostout B, Jacobson DP, Shapiro A, Sommer SS: The pattern of spontaneous germ-line mutation: Relative rates of mutation at or near CpG dinucleotides in the factor IX gene. Hum Genet 91:496, 1993
28. Noyes CM, Griffith MJ, Roberts HR, Lundblad RL: Identification of the molecular defect in factor IX Chapel Hill: Substitution of histidine for arginine at position 145. Proc Natl Acad Sci USA 80:4200, 1983
29. Thein SL, Lane DA: Use of synthetic oligonucleotides in the characterization of antithrombin III Northwick Park (393 CGT-TGT) and antithrombin III Glasgow (393 CGT-CAT). Blood 72:1817, 1988
30. Higgins DA, Schafer JA: Fibrinogen Petoskey, a dysfibrino-genemia characterized by replacement of Arg-A alpha 16 by a histidyl residue. J Biol Chem 256:12013, 1981